These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3196557)

  • 21. Citrate anticoagulation using ACD solution A during long-term haemodialysis.
    Wright S; Steinwandel U; Ferrari P
    Nephrology (Carlton); 2011 May; 16(4):396-402. PubMed ID: 21054668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Citrate for long-term hemodialysis: prospective study of 1,009 consecutive high-flux treatments in 59 patients.
    Apsner R; Buchmayer H; Gruber D; Sunder-Plassmann G
    Am J Kidney Dis; 2005 Mar; 45(3):557-64. PubMed ID: 15754278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dialysis leukopenia, hypoxemia, and anaphylatoxin formation: effect of membrane, bath, and citrate anticoagulation.
    Wiegmann TB; MacDougall ML; Diederich DA
    Am J Kidney Dis; 1988 May; 11(5):418-24. PubMed ID: 3259402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regional citrate anticoagulation for high volume continuous venovenous hemodialysis in surgical patients with high bleeding risk.
    Kalb R; Kram R; Morgera S; Slowinski T; Kindgen-Milles D
    Ther Apher Dial; 2013 Apr; 17(2):202-12. PubMed ID: 23551677
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The safety and efficacy of regional citrate anticoagulation in sustained low efficiency dialysis].
    Zhang L; Wang TL; Zhao YL; Chen ZW; Tang Y; Yang YY; Liao YJ; Fu P
    Zhonghua Nei Ke Za Zhi; 2013 Jun; 52(6):459-63. PubMed ID: 24059990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Citrate anticoagulation and divalent cations in hemodialysis.
    Janssen MJ; Huijgens PC; Bouman AA; Oe PL; van der Meulen J
    Blood Purif; 1994; 12(6):308-16. PubMed ID: 7865189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduction of granulocyte activation during hemodialysis with regional citrate anticoagulation: dissociation of complement activation and neutropenia from neutrophil degranulation.
    Böhler J; Schollmeyer P; Dressel B; Dobos G; Hörl WH
    J Am Soc Nephrol; 1996 Feb; 7(2):234-41. PubMed ID: 8785392
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simplified citrate anticoagulation for high-flux hemodialysis.
    Apsner R; Buchmayer H; Lang T; Unver B; Speiser W; Sunder-Plassmann G; Hörl WH
    Am J Kidney Dis; 2001 Nov; 38(5):979-87. PubMed ID: 11684550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Citrate versus heparin anticoagulation in chronic haemodialysis patients.
    Janssen MJ; Huijgens PC; Bouman AA; Oe PL; Donker AJ; van der Meulen J
    Nephrol Dial Transplant; 1993; 8(11):1228-33. PubMed ID: 8302461
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The favorable effect of regional citrate anticoagulation on interleukin-1beta release is dissociated from both coagulation and complement activation.
    Gabutti L; Ferrari N; Mombelli G; Keller F; Marone C
    J Nephrol; 2004; 17(6):819-25. PubMed ID: 15593057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intraoperative dialysis during liver transplantation with citrate dialysate.
    Winrow RM; Davis C; Halldorson JB; Ahmad S
    Hemodial Int; 2009 Jul; 13(3):257-60. PubMed ID: 19515070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citrate haemodialysis.
    Faber LM; de Vries PM; Oe PL; van der Meulen J; Donker AJ
    Neth J Med; 1990 Dec; 37(5-6):219-24. PubMed ID: 2074914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical evaluation of a model for prediction of end-dialysis systemic ionized calcium concentration in citrate hemodialysis.
    Thijssen S; Kossmann RJ; Kruse A; Kotanko P
    Blood Purif; 2013; 35(1-3):133-8. PubMed ID: 23343558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of coagulation and anti-Xa factor when using a heparin-coated AN69ST® dialyser.
    Sánchez-Canel JJ; Pons-Prades R; Salvetti ML; Seores A; Vázquez M; Pérez-Alba A; Tamarit E; Calvo-Gordo C; Villatoro J
    Nefrologia; 2012; 32(5):605-12. PubMed ID: 23013946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Citrate anticoagulation during plasma exchange in a patient with thrombotic thrombocytopenic purpura: short heparin-free hemodialysis helps to attenuate citrate load.
    Buturović-Ponikvar J; Pernat AM; Ponikvar R
    Ther Apher Dial; 2005 Jun; 9(3):258-61. PubMed ID: 15967002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dialyzer Performance During Hemodialysis Without Systemic Anticoagulation Using a Heparin-Grafted Dialyzer Combined With a Citrate-Enriched Dialysate: Results of the Randomized Crossover Noninferiority EvoCit Study.
    François K; De Clerck D; Tonnelier A; Cambier ML; Orlando C; Jochmans K; Cools W; Wissing KM
    Am J Kidney Dis; 2022 Jan; 79(1):79-87.e1. PubMed ID: 33940113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. pO2 and pCO2 increment in post-dialyzer blood: the role of dialysate.
    Sombolos KI; Bamichas GI; Christidou FN; Gionanlis LD; Karagianni AC; Anagnostopoulos TC; Natse TA
    Artif Organs; 2005 Nov; 29(11):892-8. PubMed ID: 16266303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Citrate clearance in children receiving continuous venovenous renal replacement therapy.
    Chadha V; Garg U; Warady BA; Alon US
    Pediatr Nephrol; 2002 Oct; 17(10):819-24. PubMed ID: 12376810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective cytopheretic inhibitory device with regional citrate anticoagulation and portable sorbent dialysis.
    Pino CJ; Farokhrani A; Lou L; Smith PL; Johnston K; Buffington DA; Humes HD
    Artif Organs; 2013 Feb; 37(2):203-10. PubMed ID: 23067378
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding.
    Pinnick RV; Wiegmann TB; Diederich DA
    N Engl J Med; 1983 Feb; 308(5):258-61. PubMed ID: 6848936
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.